CST1在胃癌进展中的作用机制及临床意义

国际肿瘤学杂志››2023,Vol. 50››Issue (8): 489-492.doi:10.3760/cma.j.cn371439-20230308-00093

CST1在胃癌进展中的作用机制及临床意义

邵慧芳¹, 王学红², 芦永福²()

¹青海大学研究生院，西宁 810016
²青海大学附属医院消化内科，西宁 810001

收稿日期:2023-03-08修回日期:2023-03-25出版日期:2023-08-08发布日期:2023-10-24
通讯作者:芦永福 E-mail:gyxb123@163.com
基金资助:
青海大学附属医院院级重点学科建设项目(青大附医政字〔2019〕195号)

Mechanism of action and clinical significance of CST1 in the progression of gastric cancer

Shao Huifang¹, Wang Xuehong², Lu Yongfu²()

¹Graduate School of Qinghai University, Xining 810016, China
²Department of Gastroenterology, Affiliated Hospital of Qinghai University, Xining 810001, China

Received:2023-03-08Revised:2023-03-25Online:2023-08-08Published:2023-10-24
Contact:Lu Yongfu E-mail:gyxb123@163.com
Supported by:
Hospital-Level Key Discipline Construction Project of the Affiliated Hospital of Qinghai University(〔2019〕195)

摘要/Abstract

摘要：

半胱氨酸蛋白酶抑制剂1（CST1）是2型Cystatins超家族成员之一，在靶向调节中起关键的作用。CST1在胃癌中呈现高表达，通过激活上皮-间质转化通路、Wnt信号通路促进肿瘤细胞的迁移和侵袭，并与同源盒C10、谷胱甘肽过氧化物酶4相应靶基因结合调控肿瘤生长和发展。深入了解CST1在胃癌中的作用和功能，有助于进一步开发针对胃癌的潜在治疗靶点和诊断及预后标志物。

关键词:胃肿瘤,半胱酸蛋白酶抑制剂1

Abstract:

Cysteine protease inhibitor 1 （CST1） is a member of type 2 Cystatins superfamily, plays a key role in targeted regulation. CST1 is highly expressed in gastric cancer, promotes tumor cell migration and invasion by activating the epithelial-mesenchymal transformation pathway and Wnt pathway, and regulates tumor growth and progression in combination with the corresponding target genes of homeobox C10 and glutathione peroxidase 4. A deeper understanding of the role and function of CST1 in gastric cancer will help to further develop potential therapeutic targets and diagnostic and prognostic markers for gastric cancer.

Key words:Stomach neoplasms,Cysteine protease inhibitor 1

邵慧芳, 王学红, 芦永福. CST1在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 489-492.

Shao Huifang, Wang Xuehong, Lu Yongfu. Mechanism of action and clinical significance of CST1 in the progression of gastric cancer[J]. Journal of International Oncology, 2023, 50(8): 489-492.

参考文献28

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3): 209-249. DOI:10.3322/caac.21660.
[2]	Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins[J].Biochem Soc Symp,2003,70: 179-199. DOI:10.1042/bss0700179.
[3]	Anastasi A, Brown MA, Kembhavi AA, et al. Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum[J].Biochem J,1983,211(1): 129-138. DOI:10.1042/bj2110129. pmid:6409085
[4]	Delimont NM, Nickel S. Salivary cystatin SN is a factor predicting iron bioavailability after phytic acid rich meals in female participants[J].Int J Food Sci Nutr,2021,72(4): 559-568. DOI:10.1080/09637486.2020.1846164.
[5]	de Sousa-Pereira P, Amado F, Abrantes J, et al. An evolutionary perspective of mammal salivary peptide families: cystatins, histatins, statherin and PRPs[J].Arch Oral Biol,2013,58(5): 451-458. DOI:10.1016/j.archoralbio.2012.12.011. pmid:23352445
[6]	Dickinson DP, Thiesse M, Dempsey LD, et al. Genomic cloning, physical mapping, and expression of human type 2 cystatin genes[J].Crit Rev Oral Biol Med,1993,4(3/4): 573-580. DOI:10.1177/10454411930040034401.
[7]	陈涛.CST1促进胃癌转移的作用及其机制研究[D]. 苏州: 苏州大学,2021. DOI:10.27351/d.cnki.gszhu.2021.001853.
[8]	Liu Y, Yao J. Research progress of cystatin SN in cancer[J].Onco Targets Ther,2019,12: 3411-3419. DOI:10.2147/OTT.S194332.
[9]	Tian S, Peng P, Li J, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway[J].Aging (Albany NY),2020,12(4): 3574-3593. DOI:10.18632/aging.102831.
[10]	Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and noncoding RNAs in the epithelial-mesenchymal transition and progression in gastric cancer[J].Int J Mol Sci,2019,20(12): 2870. DOI:10.3390/ijms20122870.
[11]	Cui Y, Sun D, Song R, et al. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis[J].J Cell Physiol,2019,234(12): 22623-22634. DOI:10.1002/jcp.28828. pmid:31106426
[12]	Yang J, Luo G, Li C, et al. Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma[J].BMC Cancer,2022,22(1): 589. DOI:10.1186/s12885-022-09685-z. pmid:35637432
[13]	Chen S, Liu Y, Zhang K, et al. CST1 promoted gastric cancer migration and invasion through activating Wnt pathway[J].Cancer Manag Res,2021,13: 1901-1907. DOI:10.2147/CMAR.S277770. pmid:33658852
[14]	Taciak B, Pruszynska I, Kiraga L, et al. Wnt signaling pathway in development and cancer[J].J Physiol Pharmacol,2018,69(2): 185-196. DOI:10.26402/jpp.2018.2.07.
[15]	Clements WM, Wang J, Sarnaik A, et al. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer[J].Cancer Res,2002,62(12): 3503-3506. pmid:12067995
[16]	Kang MH, Choi H, Oshima M, et al. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer[J].Nat Commun,2018,9(1): 1920. DOI:10.1038/s41467-018-04244-2.
[17]	Fang J, Wang J, Yu L, et al. Role of HOXC10 in cancer[J].Front Oncol,2021,11: 684021. DOI:10.3389/fonc.2021.684021.
[18]	Keppler D, Zhang J, Bihani T, et al. Novel expression of CST1 as candidate senescence marker[J].J Gerontol A Biol Sci Med Sci,2011,66(7): 723-731. DOI:10.1093/gerona/glr033.
[19]	Peng Y, Li Y, Li Y, et al. HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancer[J].Aging (Albany NY),2020,12(19): 19375-19398. DOI:10.18632/aging.103824.
[20]	Zhang X, Zheng Y, Liu X, et al. The expression of HOXC10 is correlated with tumor-infiltrating immune cells in basal-like breast cancer and serves as a prognostic biomarker[J].Ann Transl Med,2022,10(2): 81. DOI:10.21037/atm-21-6611.
[21]	Kim J, Bae DH, Kim JH, et al. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer[J].Oncol Rep,2019,42(1): 202-212. DOI:10.3892/or.2019.7164. pmid:31115563
[22]	Xu C, Liu Z, Xiao J. Ferroptosis: a double-edged sword in gastrointestinal disease[J].Int J Mol Sci,2021,22(22): 12403. DOI:10.3390/ijms222212403.
[23]	Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis[J].Proteomics,2019,19(18): e1800311. DOI:10.1002/pmic.201800311.
[24]	Zhao L, Peng Y, He S, et al. Apatinib induced ferroptosis by lipid peroxidation in gastric cancer[J].Gastric Cancer,2021,24(3): 642-654. DOI:10.1007/s10120-021-01159-8. pmid:33544270
[25]	Li D, Wang Y, Dong C, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stabi-lity via OTUB1[J].Oncogene,2023,42(2): 83-98. DOI:10.1038/s41388-022-02537-x.
[26]	王宁宁, 孙明军, 田百玲. miRNA在Hp感染相关胃癌中作用的研究进展[J].山东医药,2019,59(10): 93-96. DOI:10.3969/j.issn.1002-266X.2019.10.027.
[27]	陶清.胃癌上皮间质转化关键基因TNS1的识别和验证及临床关联研究[D]. 镇江: 江苏大学,2020. DOI:10.27170/d.cnki.gjsuu.2020.000957.
[28]	Choi EH, Kim JT, Kim JH, et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer[J].Clin Chim Acta,2009,406(1/2): 45-51. DOI:10.1016/j.cca.2009.05.008.